VaramirStart free · no cardSign in
INBX as of Nov 2 · 14:13 ET
INBXNasdaqBiological Products, (No Diagnostic Substances)

Inhibrx Biosciences, Inc. · Brief

Next report

11 days

Nov 13 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±16.4%
avg realized
±5.5%
Nov 14 '24±28.7%▼−3.49%×0.12
Mar 17 '25±27.8%▲+0.43%×0.02
May 14 '25±11.9%▲+10.89%×0.92
Aug 13 '25±18.9%▲+1.57%×0.08
Q3 FY25±18.3%▲+6.04%×0.33
Q1 FY26±6.5%▼−6.09%×0.94
May 14 '26±7.1%▼−6.47%×0.91
Q2 FY26±11.9%▼−8.91%×0.75
quarterimplied−30%0+30%realized×
Q2 FY26±11.9%▼−8.91%×0.75
May '26±7.1%▼−6.47%×0.91
Q1 FY26±6.5%▼−6.09%×0.94
Q3 FY25±18.3%▲+6.04%×0.33
Aug '25±18.9%▲+1.57%×0.08
May '25±11.9%▲+10.89%×0.92
2 older reports
Mar '25±27.8%▲+0.43%×0.02
Nov '24±28.7%▼−3.49%×0.12
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 13 report · est.

Bull2 of 3

4tracked funds holding INBXN-PORT · Aug 31 '26
164managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
0.35%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

INBX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30impliedImplied move: ±15.2% into Nov 13 earnings (Oct 30 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.